PURPOSE: The perioperative and oncological outcomes of laparoscopic radical nephrectomy (LRN) for T1-T2 renal cell carcinoma (RCC) are well established. We aim to determine whether LRN is a comparable alternative to open radical nephrectomy (ORN) in the treatment of T3 RCC using a matched pair analysis study design. METHODS: A review of a prospectively collected database at the Western General Hospital, Edinburgh, between 2000 and 2011 was conducted. Patient pairs were matched based on age at operation, gender, histological subgroup, maximal tumour diameter, TNM stage and grade. Patient demographics, operative and post-operative outcomes were compared. Overall, cancer-specific and progression-free survival [overall survival, cancer-specific survival (CSS) and progression-free survival (PFS)] were estimated using the Kaplan-Meier method. RESULTS: From 252 patients with T3 disease, 25 pairs were matched. Patients were of median age 66.2 years, 64 % male. Tumours were all clear cell RCC, were stage pT3a (32 %) or pT3b and had maximal tumour diameters of 8.7 cm for LRN and 10.0 cm for ORN. Estimated blood loss (100 ml LRN; 650 ml ORN, p < 0.001) and length of post-operative hospital stay (4 days LRN: 9 days ORN, p < 0.001) were lower in the LRN group. Operation time and post-operative complication rates were comparable. CSS and PFS were comparable with a mean CSS of 91.3 months for LRN and 88.7 months for ORN. CONCLUSION: This study reports the longest median follow-up in a T3 LRN cohort. In matched patients, LRN has been shown to have a superior perioperative profile to ORN for the treatment of pT3a/b RCC, with no adverse effect on midterm oncological outcomes.
PURPOSE: The perioperative and oncological outcomes of laparoscopic radical nephrectomy (LRN) for T1-T2 renal cell carcinoma (RCC) are well established. We aim to determine whether LRN is a comparable alternative to open radical nephrectomy (ORN) in the treatment of T3 RCC using a matched pair analysis study design. METHODS: A review of a prospectively collected database at the Western General Hospital, Edinburgh, between 2000 and 2011 was conducted. Patient pairs were matched based on age at operation, gender, histological subgroup, maximal tumour diameter, TNM stage and grade. Patient demographics, operative and post-operative outcomes were compared. Overall, cancer-specific and progression-free survival [overall survival, cancer-specific survival (CSS) and progression-free survival (PFS)] were estimated using the Kaplan-Meier method. RESULTS: From 252 patients with T3 disease, 25 pairs were matched. Patients were of median age 66.2 years, 64 % male. Tumours were all clear cell RCC, were stage pT3a (32 %) or pT3b and had maximal tumour diameters of 8.7 cm for LRN and 10.0 cm for ORN. Estimated blood loss (100 ml LRN; 650 ml ORN, p < 0.001) and length of post-operative hospital stay (4 days LRN: 9 days ORN, p < 0.001) were lower in the LRN group. Operation time and post-operative complication rates were comparable. CSS and PFS were comparable with a mean CSS of 91.3 months for LRN and 88.7 months for ORN. CONCLUSION: This study reports the longest median follow-up in a T3 LRN cohort. In matched patients, LRN has been shown to have a superior perioperative profile to ORN for the treatment of pT3a/b RCC, with no adverse effect on midterm oncological outcomes.
Authors: Grant D Stewart; W Jensen Ang; Alexander Laird; David A Tolley; Antony C P Riddick; S Alan McNeill Journal: BJU Int Date: 2012-01-30 Impact factor: 5.588
Authors: Sompol Permpongkosol; David Y Chan; Richard E Link; Myrna Sroka; Mohamad Allaf; Ioannis Varkarakis; Guilherme Lima; Thomas W Jarrett; Louis R Kavoussi Journal: J Urol Date: 2005-10 Impact factor: 7.450
Authors: Thomas J Guzzo; Edward M Schaeffer; Brian K McNeil; Richard A Pollock; Christian P Pavlovich; Mohamad E Allaf Journal: J Endourol Date: 2009-01 Impact factor: 2.942
Authors: Alexander Laird; Grant D Stewart; Jim Zhong; W J Jensen Ang; Mark L Cutress; Antony C P Riddick; S Alan McNeill; David A Tolley Journal: J Endourol Date: 2013-08 Impact factor: 2.942
Authors: Neil A Burgess; Brendan C Koo; Robert C Calvert; Andrew Hindmarsh; Peter J Donaldson; Michael Rhodes Journal: J Endourol Date: 2007-06 Impact factor: 2.942
Authors: Jasmir G Nayak; Premal Patel; Jennifer Bjazevic; Zhihui Liu; Olli Saarela; Anil Kapoor; Ricardo Rendon; Jun Kawakami; Simon Tanguay; Rodney H Breau; Peter C Black; Darrel E Drachenberg Journal: Can Urol Assoc J Date: 2015-12-14 Impact factor: 1.862